Key result
In-home biomarker assessment increased semi-annual doctor visits for previously undiagnosed high cholesterol, hypertension, and diabetes by 22 percentage points 2 years following the assessment.
Why the study?
Does in-home biomarker assessment increase doctor visits for previously undiagnosed high cholesterol, hypertension, and diabetes in Medicare beneficiaries?
Cohort (n=5,884)
Yes
Does in-home biomarker assessment increase doctor visits for previously undiagnosed high cholesterol, hypertension, and diabetes in Medicare beneficiaries?
Answers are grounded in this paper and cite their sources.
In-home biomarker assessment significantly increases subsequent doctor visits for previously undiagnosed conditions like high cholesterol, hypertension, and diabetes among Medicare beneficiaries.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Myerson et al. (2017) conducted a cohort in Previously undiagnosed high cholesterol, hypertension, and/or diabetes (n=5,884). In-home biomarker assessment and telephone outreach vs. Pre-assessment period (secular trends controlled via rolling recruitment) was evaluated on Semi-annual doctor visits for evaluation and management of previously undiagnosed conditions (22 percentage points increase, 95% CI 16-28, p=<0.01). In-home biomarker assessment increased semi-annual doctor visits for previously undiagnosed high cholesterol, hypertension, and diabetes by 22 percentage points 2 years following the assessment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: